opsynvi
Generic: macitentan and tadalafil
Labeler: actelion pharmaceuticals us, inc.Drug Facts
Product Profile
Brand Name
opsynvi
Generic Name
macitentan and tadalafil
Labeler
actelion pharmaceuticals us, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
macitentan 10 mg/1, tadalafil 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
66215-812
Product ID
66215-812_32840e17-39b6-50b2-e063-6394a90a7a37
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA218490
Listing Expiration
2026-12-31
Marketing Start
2024-03-22
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
66215812
Hyphenated Format
66215-812
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
opsynvi (source: ndc)
Generic Name
macitentan and tadalafil (source: ndc)
Application Number
NDA218490 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
- 20 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (66215-812-07) / 7 TABLET, FILM COATED in 1 BOTTLE
- 1 BLISTER PACK in 1 CARTON (66215-812-08) / 7 TABLET, FILM COATED in 1 BLISTER PACK (66215-812-01)
- 1 BOTTLE in 1 CARTON (66215-812-30) / 30 TABLET, FILM COATED in 1 BOTTLE
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "32840e17-39b6-50b2-e063-6394a90a7a37", "openfda": {"nui": ["N0000175599", "N0000020026", "N0000175581", "N0000175364"], "unii": ["742SXX0ICT", "Z9K9Y9WMVL"], "rxcui": ["2677765", "2677771", "2677773", "2677775"], "spl_set_id": ["6945b183-18d3-40de-afd1-c88e33cc1a63"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]", "Endothelin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]", "Endothelin Receptor Antagonists [MoA]"], "manufacturer_name": ["Actelion Pharmaceuticals US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (66215-812-07) / 7 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "66215-812-07", "marketing_start_date": "20240322"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (66215-812-08) / 7 TABLET, FILM COATED in 1 BLISTER PACK (66215-812-01)", "package_ndc": "66215-812-08", "marketing_start_date": "20240322"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (66215-812-30) / 30 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "66215-812-30", "marketing_start_date": "20240322"}], "brand_name": "OPSYNVI", "product_id": "66215-812_32840e17-39b6-50b2-e063-6394a90a7a37", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Endothelin Receptor Antagonist [EPC]", "Endothelin Receptor Antagonists [MoA]", "Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "66215-812", "generic_name": "macitentan and tadalafil", "labeler_name": "Actelion Pharmaceuticals US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OPSYNVI", "active_ingredients": [{"name": "MACITENTAN", "strength": "10 mg/1"}, {"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "NDA218490", "marketing_category": "NDA", "marketing_start_date": "20240322", "listing_expiration_date": "20261231"}